Topical antibiotic trends from 1993 to 2007: Use of topical antibiotics for non-evidence-based indications

Dermatologic Surgery

Volumn 37, Issue 10, 2011, Pages 1427-1433

  Lapolla, Whitney J ^a   Levender, Michelle M ^a   Davis, Scott A ^a   Yentzer, Brad A ^a   Williford, Phillip M ^a   Feldman, Steven R ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Center for Dermatology Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN PLUS POLYMYXIN B; NEOMYCIN; PSEUDOMONIC ACID; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CELLULITIS; CHILD; DEMOGRAPHY; DRUG ADMINISTRATION ROUTE; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; IMPETIGO; INFANT; INSECT BITE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; SKIN CANCER; SKIN SURGERY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DERMATOLOGY; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; SKIN DISEASES; YOUNG ADULT;

EID: 80053907555     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.02122.x     Document Type: Article

References (28)

1. van Rijen MM, Kluytmans JA., New approaches to prevention of staphylococcal infection in surgery. Curr Opin Infect Dis 2008; 21: 380-4.
2. Thornton SC, Taylor SC, Weinberg JM., Topical antimicrobial agents in dermatology. Clin Dermatol 2003; 21: 70-7.
3. Hirschmann JV., Topical antibiotics in dermatology. Arch Dermatol 1988; 124: 1691-700.
4. Rosengren H, Dixon A., Antibacterial prophylaxis in dermatologic surgery: an evidence-based review. Am J Clin Dermatol 2010; 11: 35-44.
5. Haas AF, Grekin RC., Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995; 32: 155-76.
6. Smack DP, Harrington AC, Dunn C, Howard RS, et al,. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA 1996; 276: 972-7.
7. Campbell RM, Perlis CS, Fisher E, Gloster HM Jr. , Gentamicin ointment versus petrolatum for management of auricular wounds. Dermatol Surg 2005; 31: 664-9.
8. About the ambulatory care surveys. Office of Information Services. The Center for Disease Control and Prevention. 7-14-2009.
9. Margolis DJ, Bowe WP, Hoffstad O, Berlin JA., Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005; 141: 1132-6.
10. Mills O Jr. , Thornsberry C., Cardin CW, Smiles KA, et al,. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol 2002; 82: 260-5.
11. Leyden JJ, Del Rosso JQ, Webster GF., Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis 2007; 79: 9-25.
12. Harkaway KS, McGinley KJ, Foglia AN, Lee WL, et al,. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 1992; 126: 586-90.
13. Sheth VM, Weitzul S., Postoperative topical antimicrobial use. Dermatitis 2008; 19: 181-9.
14. Cronin H, Mowad C., Anaphylactic reaction to bacitracin ointment. Cutis 2009; 83: 127-9.
15. Greenberg K, Espinosa J, Scali V., Anaphylaxis to topical bacitracin ointment. Am J Emerg Med 2007; 25: 95-6.
16. Brian MJ., Mupirocin-resistant MRSA transmission associated with community hospitals and nursing homes. J Hosp Infect 2010; 75: 141-2.
17. Mulvey MR, MacDougall L, Cholin B, Horsman G, et al,. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005; 11: 844-50.
18. Del Rosso JQ, Kim GK., Topical antibiotics: therapeutic value or ecologic mischief? Dermatol Ther 2009; 22: 398-406.
19. George A, Rubin G., A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract 2003; 53: 480-7.
20. Mertz PM, Marshall DA, Eaglstein WH, Piovanetti Y, et al,. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch Dermatol 1989; 125: 1069-73.
21. Rist T, Parish LC, Capin LR, Sulica V, et al,. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema. Clin Exp Dermatol 2002; 27: 14-20.
22. Wright TI, Baddour LM, Berbari EF, Roenigk RK, et al,. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol 2008; 59: 464-73.
23. Alsterholm M, Karami N, Faergemann J., Antimicrobial activity of topical skin pharmaceuticalsa - an in vitro study. Acta Derm Venereol 2010; 90: 239-45.
24. McDonnell G, Russell AD., Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-79.
25. Koay J, Orengo I., Application of local anesthetics in dermatologic surgery. Dermatol Surg 2002; 28: 143-8.
26. Gelmetti C., Local antibiotics in dermatology. Dermatol Ther 2008; 21: 187-95.
27. Stevens DL, Eron LL., Cellulitis and soft-tissue infections. Ann Intern Med 2009; 150: ITC11.
28. Laupland KB, Conly JM., Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003; 37: 933-8.